Hosted on MSN
PacBio Stock Soars On Plans To Reduce Spending Over NIH Funding Uncertainty, Tariffs: Retail Is Overjoyed
Shares of PacBio (PACB) traded nearly 20% higher on Wednesday after the company said it is executing a plan, including job cuts, to reduce the annualized operating expense run rate by $45 million to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback